Edwards Lifesciences EW
NYSE EW
$86.14 -0.58 (-0.67%)
As of: Sep 9, 2026 · 2:31 PM EDT

Edwards Lifesciences (EW) Interest Expenses (2009 - 2017)

Edwards Lifesciences (EW) posted Interest Expenses of $19.3 million for Q4 2017, up 19200.0% on a QoQ basis from $100000.0 in Q3 2017, and up 56.91% year-over-year from $12.3 million in Q4 2016.

Analysis

Edwards Lifesciences (EW) Interest Expenses (2009 - 2017) Analysis & Trends

Edwards Lifesciences has reported Interest Expenses for 4 years, with the latest figure at $19.3 million in Q4 2017.

  • On a quarterly basis, Interest Expenses rose 56.91% year-over-year to $19.3 million in Q4 2017; TTM through Dec 2017 was $23.2 million, a 20.83% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 3.03% from the prior year.
  • Interest Expenses was $19.3 million for Q4 2017 at Edwards Lifesciences, up from $100000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $19.3 million in Q4 2017, with the low at $100000.0 in Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Abbott Laboratories 183.84 Bn 178.24 Bn 7.27 Bn 351.00 Mn
2 Intuitive Surgical 124.30 Bn 119.09 Bn 1.96 Bn -
3 Medtronic 118.47 Bn 109.65 Bn 6.34 Bn 186.00 Mn
4 Stryker 106.24 Bn 102.77 Bn 4.50 Bn 141.00 Mn
5 Boston Scientific 66.67 Bn 66.13 Bn 3.85 Bn 96.00 Mn
6 Edwards Lifesciences 49.69 Bn 45.43 Bn 1.35 Bn -
7 Alcon 34.03 Bn 32.57 Bn 1.68 Bn -53.00 Mn
8 Dexcom 32.09 Bn 30.14 Bn 830.00 Mn -
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn 15.80 Mn
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 19.30 Mn
Sep 30, 2017 100,000.00
Jun 30, 2017 1.40 Mn
Mar 31, 2017 2.40 Mn
Dec 31, 2016 12.30 Mn
Sep 30, 2016 2.10 Mn
Jun 30, 2016 2.40 Mn
Mar 31, 2016 2.40 Mn
Dec 31, 2010 3.50 Mn
Sep 30, 2010 -400,000.00
Jun 30, 2010 -500,000.00
Mar 31, 2010 -200,000.00
Dec 31, 2009 3.60 Mn
Sep 30, 2009 -600,000.00
Jun 30, 2009 -200,000.00